EUMOVATE DIN 02214423
Status: Cancelled Post Market
Holder: GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
Molecule: CLOBETASONE BUTYRATE
Health Canada record
| Active ingredient(s) | CLOBETASONE BUTYRATE 0.05 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AB01 CLOBETASONE |
| Original market date | 25-Jun-2001 |
| Current status date | 02-Aug-2007 |
| Source | Health Canada DPD |
Establishment licence of the holder
GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOBETASONE BUTYRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02214415 | SPECTRO ECZEMACARE MEDICATED CREAM | HALEON CANADA ULC | Cream | CLOBETASONE BUTYRATE 0.05 % | Marketed |
| 00456543 | EUMOVATE CRM 0.05% | GLAXO CANADA INC | Cream | CLOBETASONE BUTYRATE 0.05 % | Cancelled Post Market |
| 00456551 | EUMOVATE ONT 0.05% | GLAXO CANADA INC | Ointment | CLOBETASONE BUTYRATE 0.05 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 387 | 2002-02-19 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2115 | 2001-08-15 | New Drug Submission (NDS) | CHANGE IN MANUFACTURER NAME |
International API supply for CLOBETASONE BUTYRATE
1 valid EDQM Certificates of Suitability from 1 holders.
Request a quote for EUMOVATE